Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis

Neurobiology of Aging

Volumn 35, Issue 4, 2014, Pages 936.e1-936.e4

  Figley, Matthew D ^a   Thomas, Anna ^a,b   Gitler, Aaron D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Presentation High School   (United States)

Author keywords

ALS; Ataxin; Noncoding; Nucleotide repeat expansion; PolyQ

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATXN10 GENE; ATXN8 GENE; CONTROLLED STUDY; DMPK GENE; GENE; GENE FUNCTION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; JPH3 GENE; MAJOR CLINICAL STUDY; NOP56 GENE; NUCLEOTIDE REPEAT; PPP2R2B GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ALS; ATAXIN; NONCODING; NUCLEOTIDE REPEAT EXPANSION; POLYQ;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OPEN READING FRAMES; PEPTIDES; PROTEIN PHOSPHATASE 2; PROTEIN-SERINE-THREONINE KINASES; REPETITIVE SEQUENCES, NUCLEIC ACID; RISK FACTORS; RNA, UNTRANSLATED; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 85058205487     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.09.024     Document Type: Article

References (15)

1. Blauw H.M., van Rheenen W., Koppers M., Van Damme P., Waibel S., Lemmens R., van Vught P.W., Meyer T., Schulte C., Gasser T., Cuppen E., Pasterkamp R.J., Robberecht W., Ludolph A.C., Veldink J.H., van den Berg L.H. NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012, 21:2497-2502.
2. Conforti F.L., Spataro R., Sproviero W., Mazzei R., Cavalcanti F., Condino F., Simone I.L., Logroscino G., Patitucci A., Magariello A., Muglia M., Rodolico C., Valentino P., Bono F., Colletti T., Monsurro M.R., Gambardella A., La Bella V. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 2012, 79:2315-2320.
3. Cooper T.A., Wan L., Dreyfuss G. RNA and disease. Cell 2009, 136:777-793.
4. Day J.W., Schut L.J., Moseley M.L., Durand A.C., Ranum L.P. Spinocerebellar ataxia type 8: clinical features in a large family. Neurology 2000, 55:649-657.
5. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
6. Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., Padmanabhan A., Clay-Falcone D., McCluskey L., Elman L., Juhr D., Gruber P.J., Rub U., Auburger G., Trojanowski J.Q., Lee V.M., Van Deerlin V.M., Bonini N.M., Gitler A.D. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 2010, 466:1069-1075.
7. Fischbeck K.H., Pulst S.M. Amyotrophic lateral sclerosis and spinocerebellar ataxia 2. Neurology 2011, 76:2050-2051.
8. Garcia-Murias M., Quintans B., Arias M., Seixas A.I., Cacheiro P., Tarrio R., Pardo J., Millan M.J., Arias-Rivas S., Blanco-Arias P., Dapena D., Moreira R., Rodriguez-Trelles F., Sequeiros J., Carracedo A., Silveira I., Sobrido M.J. 'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization. Brain 2012, 135:1423-1435.
9. Groen E.J., van Rheenen W., Koppers M., van Doormaal P.T., Vlam L., Diekstra F.P., Dooijes D., Pasterkamp R.J., van den Berg L.H., Veldink J.H. CGG-repeat expansion in FMR1 is not associated with amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33. 1852.e1851-1852.e1853.
10. Lee T., Li Y.R., Chesi A., Hart M.P., Ramos D., Jethava N., Hosangadi D., Epstein J., Hodges B., Bonini N.M., Gitler A.D. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology 2011, 76:2062-2065.
11. Li L.B., Bonini N.M. Roles of trinucleotide-repeat RNA in neurological disease and degeneration. Trends Neurosci. 2010, 33:292-298.
12. Ling S.C., Polymenidou M., Cleveland D.W. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron 2013, 79:416-438.
13. Orr H.T., Zoghbi H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 2007, 30:575-621.
14. Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Holtta-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268.
15. Todd P.K., Paulson H.L. RNA-mediated neurodegeneration in repeat expansion disorders. Ann. Neurol. 2010, 67:291-300.